Filter
261
Text search:
antibacterial
Featured
Recommendations
29
New Publications
65
Language
Document type
No document type
79
Studies & Reports
76
Guidelines
62
Fact sheets
11
Manuals
10
Strategic & Response Plan
10
Training Material
4
Brochures
3
Situation Updates
3
Infographics
2
Online Courses
1
Countries / Regions
Ethiopia
12
India
12
Kenya
11
Colombia
6
Nigeria
5
Western and Central Europe
5
South Africa
4
Africa
4
Venezuela
4
Global
4
Ghana
3
Uganda
3
Nepal
3
Bangladesh
3
Argentina
3
Madagascar
3
Eastern Europe and Central Asia
3
Sierra Leone
2
Tanzania
2
Thailand
2
Malawi
2
Peru
2
Lesotho
2
Myanmar / Burma
2
Middle East and North Africa
2
Latin America and the Carribbean
2
Russia
2
Burkina Faso
1
Liberia
1
Zimbabwe
1
Philippines
1
Pakistan
1
Jordan
1
Zambia
1
China
1
Indonesia
1
Mozambique
1
Papua New Guinea
1
Sudan
1
Namibia
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Ukraine
1
Honduras
1
Ecuador
1
Botswana
1
Bolivia
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Bhutan
1
Eastern Europe
1
Armenia
1
Mongolia
1
Tajikistan
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Denmark
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
86
Clinical Guidelines
21
Women & Child Health
6
Pharmacy & Technologies
5
Key Resources
4
Public Health
3
Capacity Building
1
Toolboxes
AMR
100
COVID-19
22
Pharmacy
22
TB
19
Rapid Response
8
NTDs
8
Ebola
7
Planetary Health
5
Cholera
3
Conflict
3
Caregiver
3
Disability
2
HIV
2
Zika
1
Mental Health
1
Specific Hazards
1
Global Health Education
1
Health Financing Toolbox
1
NCDs
1
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-incr
...
Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug consumers. These coupled with rapid spread of res
...
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for
...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treati
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
Haematologica has published European guidelines for empirical and targeted antibacterial therapy forfebrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes
...
During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of antiviral and
...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs
...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is hi
...
The era of effective antibiotics is coming to a close. In just a few generations, many “miracle medicines”have been beaten into ineffectiveness by the bacteria they were intended to eradicate. Bacteria quickly adapt to the presence of
...
WHO CIA list categorizes all antimicrobials used in human medicine into 3 groups based on their importance to human medicine. The current scope is limited to antibacterial drugs of which most are also used in
...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim
...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i
...
Here you can find online courses on drug development, Pharmacology of Antibacterial Agents, pharmaceutical devices, etc.
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
